Seagen Inc. Insider Trading for March 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Seagen Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Seagen Inc. for March 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 22 2018 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Option Exercise | M | 12.00 | 13,740 | 164,880 | 45,000 | |
| Mar 22 2018 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Option Exercise | M | 10.61 | 7,000 | 74,270 | 0 | |
| Mar 22 2018 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Option Exercise | M | 26.10 | 3,831 | 99,989 | 0 | |
| Mar 22 2018 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Option Exercise | M | 15.46 | 6,468 | 99,995 | 0 | |
| Mar 22 2018 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Buy | M | 10.61 | 7,000 | 74,270 | 201,973 | 195 K to 202 K (+3.59 %) |
| Mar 22 2018 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Buy | M | 12.00 | 13,740 | 164,880 | 194,973 | 181.2 K to 195 K (+7.58 %) |
| Mar 22 2018 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Buy | M | 15.46 | 6,468 | 99,995 | 181,233 | 174.8 K to 181.2 K (+3.70 %) |
| Mar 22 2018 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Buy | M | 26.10 | 3,831 | 99,989 | 174,765 | 170.9 K to 174.8 K (+2.24 %) |
| Mar 22 2018 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | See Remarks | Option Exercise | A | 34.20 | 10,526 | 359,989 | 10,526 | |
| Mar 22 2018 | SGEN | SEATTLE GENETICS I ... | Cline Darren S | See Remarks | Option Exercise | A | 34.20 | 8,333 | 284,989 | 8,333 | |
| Mar 22 2018 | SGEN | SEATTLE GENETICS I ... | LIU JEAN I | GC & EVP, Legal Aff ... | Option Exercise | A | 34.20 | 8,333 | 284,989 | 8,333 | |
| Mar 22 2018 | SGEN | SEATTLE GENETICS I ... | SIMPSON TODD E | Chief Financial Off ... | Option Exercise | A | 34.20 | 10,526 | 359,989 | 10,526 | |
| Mar 22 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President & CEO | Option Exercise | A | 34.20 | 37,280 | 1,274,976 | 37,280 | |
| Mar 22 2018 | SGEN | SEATTLE GENETICS I ... | HIMES VAUGHN B | Chief Technical Off ... | Option Exercise | A | 34.20 | 8,333 | 284,989 | 8,333 | |
| Mar 19 2018 | SGEN | SEATTLE GENETICS I ... | HIMES VAUGHN B | See Remarks | Option Exercise | M | 12.00 | 5,000 | 60,000 | 51,498 | |
| Mar 19 2018 | SGEN | SEATTLE GENETICS I ... | HIMES VAUGHN B | See Remarks | Sell | S | 58.86 | 200 | 11,772 | 164,906 | 165.1 K to 164.9 K (-0.12 %) |
| Mar 19 2018 | SGEN | SEATTLE GENETICS I ... | HIMES VAUGHN B | See Remarks | Sell | S | 58.09 | 4,800 | 278,832 | 165,106 | 169.9 K to 165.1 K (-2.83 %) |
| Mar 19 2018 | SGEN | SEATTLE GENETICS I ... | HIMES VAUGHN B | See Remarks | Buy | M | 12.00 | 5,000 | 60,000 | 169,906 | 164.9 K to 169.9 K (+3.03 %) |
| Mar 15 2018 | SGEN | SEATTLE GENETICS I ... | Seth Alpna | Director | Option Exercise | A | 57.68 | 14,250 | 821,940 | 14,250 | |
| Mar 15 2018 | SGEN | SEATTLE GENETICS I ... | Seth Alpna | Director | Grant | A | 0.00 | 5,750 | 0 | 5,750 | 0 to 5.8 K |
| Mar 13 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 11.09 | 14,068 | 156,014 | 94,159 | |
| Mar 13 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 11.09 | 4,764 | 52,833 | 108,227 | |
| Mar 13 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 57.17 | 14,068 | 804,268 | 687,146 | 701.2 K to 687.1 K (-2.01 %) |
| Mar 13 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 11.09 | 14,068 | 156,014 | 701,214 | 687.1 K to 701.2 K (+2.05 %) |
| Mar 13 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 57.76 | 4,764 | 275,169 | 687,146 | 691.9 K to 687.1 K (-0.69 %) |
| Mar 13 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 11.09 | 4,764 | 52,833 | 691,910 | 687.1 K to 691.9 K (+0.69 %) |
| Mar 07 2018 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Option Exercise | M | 8.96 | 3,257 | 29,183 | 0 | |
| Mar 07 2018 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Option Exercise | M | 8.96 | 7,200 | 64,512 | 3,257 | |
| Mar 07 2018 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Sell | S | 53.12 | 3,257 | 173,012 | 170,934 | 174.2 K to 170.9 K (-1.87 %) |
| Mar 07 2018 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Buy | M | 8.96 | 3,257 | 29,183 | 174,191 | 170.9 K to 174.2 K (+1.91 %) |
| Mar 07 2018 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Sell | S | 52.70 | 7,200 | 379,440 | 170,934 | 178.1 K to 170.9 K (-4.04 %) |
| Mar 07 2018 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Buy | M | 8.96 | 7,200 | 64,512 | 178,134 | 170.9 K to 178.1 K (+4.21 %) |